This finding was further confirmed in a single-cell study examining the CPI response in CRC, where patients with an elevated baseline level of CD8+ CXCL13+ cells have been shown to present a complete response to treatment [34]. The gene discussed is CD8A; the disease is colorectal carcinoma.